Safety worries spur Pfizer to drop another obesity pill

Signs of potential liver damage in a study participant led the company to abandon danuglipron, a drug it hoped would help it break into the highly lucrative market for obesity drugs.

Biogen builds case for Spinraza successor with fresh data

March 11, 2026

Group seeks industry-wide boycott of upcoming Africa Energies Summit – EnviroNews

March 11, 2026

Source link

Safety worries spur Pfizer to drop another obesity pill

Biogen builds case for Spinraza successor with fresh data

Group seeks industry-wide boycott of upcoming Africa Energies Summit – EnviroNews

Meet the Top Global Franchise Brands in Miami This May

Health and Human Services Systems Are in Danger of Collapsing, Workers Say

Health and Human Services Systems Are in Danger of Collapsing, Workers Say

Leave a Reply Cancel reply

RECOMMENDED NEWS

Lagos: 19th best city in the world?

Zimbabwe may permit the reintroduction of mobile money agents

SnuzPod4 Bassinet Review: A Great-Looking and Simple Bassinet

From the UK: What is Technocracy?

POPULAR NEWS

Mahama attends Liberia’s 178th independence anniversary

Ghana to build three oil refineries, five petrochemical plants in energy sector overhaul

The world’s top 10 most valuable car brands in 2025

Top 10 African countries with the highest GDP per capita in 2025

Global ranking of Top 5 smartphone brands in Q3, 2024

Safety worries spur Pfizer to drop another obesity pill

Related posts

Meet the Top Global Franchise Brands in Miami This May

Health and Human Services Systems Are in Danger of Collapsing, Workers Say

Leave a Reply Cancel reply

RECOMMENDED NEWS

POPULAR NEWS